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Following publication of the original article \[[@CR1]\], the author noticed that there are some errors with Table [1](#Tab1){ref-type="table"} and Table [2](#Tab2){ref-type="table"}. Please see the correct tables below. The authors apologize for any inconvenience caused.Table 1Comparison of mRNA expression of MCMs in glioma tumor tissue by qRT-PCR and microarray analysisGeneUnique IDGene originFold*p* valueII/NormalIII/NormalIV/NormalIII/IIIV/IIIV/III(II-IV)/NormalII → NormalIII → NormalIV → NormalIII → IIIV → IIIV → IIIMCM2202107_s\_atqRT-PCR1.973.984.522.022.291.143.51.59E-022.15E-043.97E-043.80E-036.10E-048.31E-02Microarray1.683.745.212.233.101.393.42E-022.98E-051.75E-088.38E-097.03E-061.26E-06MCM3201555_atqRT-PCR1.513.354.292.222.841.283.11.37E-021.95E-032.73E-041.89E-021.10E-031.72E-03Microarray1.842.622.911.421.581.114.85E-032.66E-053.71E-061.06E-029.77E-076.82E-04MCM4222036_s\_atqRT-PCR2.074.296.682.073.231.564.36.21E-024.36E-022.53E-027.30E-024.26E-026.82E-02Microarray1.932.473.931.282.041.597.19E-021.82E-023.68E-036.01E-032.89E-034.29E-03MCM5201755_atqRT-PCR1.773.516.051.983.421.723.81.49E-021.38E-035.05E-041.32E-021.67E-037.29E-03Microarray0.951.632.891.723.041.775.91E-032.79E-035.81E-033.09E-048.59E-071.23E-03MCM6201930_atqRT-PCR1.553.894.952.513.191.273.53.96E-021.05E-021.16E-022.65E-021.17E-027.92E-02Microarray2.652.884.751.091.791.659.12E-031.07E-046.77E-048.10E-095.24E-031.42E-03MCM7208795_s\_atqRT-PCR1.533.084.522.012.951.473.03.82E-022.02E-039.81E-031.25E-021.20E-034.01E-03Microarray1.312.823.612.152.761.281.59E-045.09E-043.80E-044.79E-089.28E-086.36E-02MCM10220651_s\_atqRT-PCR2.173.595.051.652.331.413.63.90E-024.50E-041.46E-042.96E-021.88E-032.60E-03Microarray6.9223.8727.963.454.041.171.37E-035.39E-087.61E-095.86E-072.59E-095.83E-02MCM3 and MCM5, MCM7 and MCM10 were significant different between grade II, III and IV samples (*p* \< 0.05). MCM2 and MCM6 expressions were significantly increased between grade II (low grade) and III-IV (high grade) samples (*p* \< 0.05)Table 2Multivariate analysis on prognosis of the patients (*n* = 51)ParameterRisk ratio95% CI*p*Sex2.0670.789--4.6700.151Age (≥40)3.1551.984--4.0390.042WHO (Grade 4)3.08431.523--3.8100.034MCM28.5196.280--10.5080.004MCM37.3285.102--9.8330.007MCM40.5060.843--1.4410.477MCM52.1170.946--3.1270.146MCM62.8731.377--4.0730.090MCM76.5764.114--8.2430.010MCM100.0290.015--1.0930.937
